PRESS RELEASE |

Sarah Larcker Named to MM+M 40 Under 40

MediFind CMO and Head of Growth Sarah Larcker has been named to MM+M’s 40 Under 40, honoring the industry’s best-regarded young talent.

“Among the many reasons the medical marketing business continues to thrive is the abundance of top-flight talent in its ranks. Other verticals are jealous, frankly,” said MM+M editor-in-chief Larry Dobrow. “While that makes the 40 Under 40 selection process a challenge, it’s one that we embrace. It’s a privilege to celebrate the individuals set to lead the business for years to come.”

The honorees will be celebrated at an event on February 16, 2023 in New York City. See all the full “class of 2023” here.

Sarah Larcker thumbnail

About Phreesia Life Sciences

Phreesia is the trusted leader in patient activation, giving providers, health plans, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 120 million patient visits in 2022—more than 1 in 10 visits across the U.S.—scale that we believe allows us to make meaningful impact. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives efficiency and improves healthcare outcomes. To learn more, visit phreesia.com.

Press contact:

Carly Helfand
chelfand@phreesia.com
332-910-6768